Preengraftment Serum C-Reactive Protein (CRP) Value May Predict Acute Graft-versus-Host Disease and Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 5, 2008, Pages 510-517

  Fuji, Shigeo ^a   Kim, Sung Won ^a   Fukuda, Takahiro ^a   Mori, Shin ichiro ^a   Yamasaki, Satoshi ^a   Morita Hoshi, Yuriko ^a   Ohara Waki, Fusako ^a   Heike, Yuji ^a   Tobinai, Kensei ^a   Tanosaki, Ryuji ^a   Takaue, Yoichi ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Acute graft versus host disease; Allogeneic transplantation; C reactive protein; Nonrelapse mortality

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; AMPHOTERICIN B; BUSULFAN; C REACTIVE PROTEIN; CEFEPIME; CIPROFLOXACIN; CLADRIBINE; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; TACROLIMUS; VANCOMYCIN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIAL INFECTION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DONOR; FEMALE; HERPES; HLA MATCHING; HUMAN; IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; MYCOSIS; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHODGKIN LYMPHOMA; PNEUMOCYSTOSIS; PROTEIN BLOOD LEVEL; REDUCED INTENSITY CONDITIONING; RELAPSE; RISK FACTOR; SEX DIFFERENCE; SHORT COURSE THERAPY; VIRUS INFECTION; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 41849122729     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.02.008     Document Type: Article

References (26)

1. Wojnar J., Giebel S., Krawczyk-Kulis M., et al. Acute graft-versus-host disease. The incidence and risk factors. Ann Transplant 11 (2006) 16-23
2. Weisdorf D., Hakke R., Blazar B., et al. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51 (1991) 1197-1203
3. Krenger W., Hill G.R., and Ferrara J.L. Cytokine cascades in acute graft-versus-host disease. Transplantation 64 (1997) 553-558
4. Ferrara J.L. The cytokine modulation of acute graft-versus-host disease. Bone Marrow Transplant 21 Suppl 3 (1998) S13-S15
5. Cooke K.R., Olkiewicz K., Erickson N., and Ferrara J.L. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J Endotoxin Res 8 (2002) 441-448
6. Toren A., Novick D., Or R., Ackerstein A., Slavin S., and Nagler A. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation. Transplantation 62 (1996) 138-142
7. Liem L.M., van Houwelingen H.C., and Goulmy E. Serum cytokine levels after HLA-identical bone marrow transplantation. Transplantation 66 (1998) 863-871
8. Schwaighofer H., Herold M., Schwarz T., et al. Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation. Transplantation 58 (1994) 430-436
9. Chasty R.C., Lamb W.R., Gallati H., Roberts T.E., Brenchley P.E., and Yin J.A. Serum cytokine levels in patients undergoing bone marrow transplantation. Bone Marrow Transplant 12 (1993) 331-336
10. Lange A., Karabon L., Klimczak A., et al. Serum interferon-gamma and C-reactive protein levels as predictors of acute graft-vs-host disease in allogeneic hematopoietic precursor cell (marrow or peripheral blood progenitor cells) recipients. Transplant Proc 28 (1996) 3522-3525
11. Symington F.W., Symington B.E., Liu P.Y., Viguet H., Santhanam U., and Sehgal P.B. The relationship of serum IL-6 levels to acute graft-versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation 54 (1992) 457-462
12. Fowler D.H., Foley J., Whit-Shan Hou J., et al. Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease. Clin Gastroenterol Hepatol 2 (2004) 237-245
13. Antin J.H., and Ferrara J.L. Cytokine dysregulation and acute graft-versus-host disease. Blood 80 (1992) 2964-2968
14. Heinrich P.C., Castell J.V., and Andus T. Interleukin-6 and the acute phase response. Biochem J 265 (1990) 621-636
15. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
16. Santolaya M.E., Cofre J., and Beresi V. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis 18 (1994) 589-595
17. Manian F.A. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia. Clin Infect Dis 21 (1995) 114-121
18. Persson L., Engervall P., Magnuson A., et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 36 (2004) 365-371
19. von Lilienfeld-Toal M., Dietrich M.P., Glasmacher A., et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 23 (2004) 539-544
20. Rintala E., Remes K., Salmi T.T., Koskinen P., and Nikoskelainen J. The effects of pretransplant conditioning, graft-versus-host disease and sepsis on the CRP levels in bone marrow transplantation. Infection 25 (1997) 335-338
21. Schots R., Kaufman L., Van Riet I., et al. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplant 22 (1998) 79-85
22. Schots R., Van Riet I., Ben Othman T., et al. An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transplant 30 (2002) 441-446
23. Min C.K., Kim S.Y., Eom K.S., et al. Patterns of C-reactive protein release following allogeneic stem cell transplantation are correlated with leukemic relapse. Bone Marrow Transplant 37 (2006) 493-498
24. Pihusch M., Pihusch R., Fraunberger P., et al. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 76 (2006) 93-101
25. Przepiorka D., Weisdorf D., Martin P., et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
26. Cooke K.R., Gerbitz A., Crawford J.M., et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. J Clin Invest 107 (2001) 1581-1589